Novo Nordisk announces rebrand amid competition with Eli Lilly
The two pharma giants are in competition for dominance in the obesity and diabetes markets.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
The two pharma giants are in competition for dominance in the obesity and diabetes markets.
Increased access to naloxone and harm reduction supplies have made an impact, according to a recent analysis.
The largest percentage is non-melanoma skin cancer, according to federal data.
Longer wait times could lead to worse health outcomes.
The medicine doubled survival time for patients in a Phase 3 clinical trial.
The companies say the treatment slowed melanoma recurrence and spread in the trial.
The company said the scams don’t reflect any security concerns with the patient portal.
Allina Health will soon open a new $1 billion surgical center focused on complex procedures.
The drugmakers are looking for ways to make the medicines more effective, and to expand their reach beyond weight loss and diabetes.
The company is looking to compete with Epic, the largest EHR vendor in the US.